Artificially generated data mimicking real data properties.
In media and creative work, 'synthetic data' is heard as synthetic content: AI-generated or manipulated images, audio, and video whose resemblance to real people, places, or events makes them false-authenticity risks rather than modeling inputs. The operative duties are disclosure and marking — the AI Act defines deep fakes as AI-generated content that would falsely appear authentic, requires machine-readable marking of generated output, and obliges deployers of deep fakes to disclose the manipulation — so newsroom and platform practice centers on labeling pipelines, provenance credentials, and editorial rules for when synthetic material may be used at all.
In practice: Label and mark AI-generated or manipulated content, verify provenance before publication, and apply editorial disclosure rules whenever synthetic material could be mistaken for captured reality.
OmniGloss seed synthesis, 2026 (machine-drafted, pending expert validation)
In bank technology and data functions, synthetic data is an enabler of development at arm's length from customers: generated transaction and account records that behave like production data are used to test systems, develop fraud and credit models, and share working examples with vendors and offshore teams. The operational premise is that properly generated records have no one-to-one correspondence to any customer, so the datasets are handled as non-personal, escaping the transfer and minimisation constraints that would otherwise stall projects. Model validation still demands real outcomes — synthetic data supports build and test, not final performance evidence.
In practice: Use generated data to develop and test systems without exposing customer records, while documenting the generation method and keeping final model validation on real outcome data.
OmniGloss seed synthesis, 2026 (machine-drafted, pending expert validation)
In health-data research, synthetic data means artificially generated patient-level records that reproduce the statistical structure of a real cohort so that method development, teaching, and code testing can happen without moving real records. Working practice evaluates each synthetic release on two axes: fidelity (marginals, correlations, downstream task performance against the real data) and privacy (membership-inference and attribute-disclosure testing), because generative models can memorize rare patients. A synthetic dataset is therefore cleared per release, with measured utility and measured leakage — generation alone is not accepted as proof that no patient is exposed.
In practice: Evaluate every synthetic health dataset for both fidelity and empirical privacy leakage before release, and never substitute it for real-data validation of clinical performance claims.
OmniGloss seed synthesis, 2026 (machine-drafted, pending expert validation)
In compliance work around medical AI, synthetic data functions as the legally preferred alternative: the AI Act permits providers to process special categories of personal data for bias detection and correction only where that purpose cannot be effectively fulfilled with other data, including synthetic or anonymised data, and ethics committees increasingly ask the same question of study designs. Teams must therefore show they considered a synthetic route before touching sensitive records — synthetic data operates as the benchmark of a necessity test, shifting the burden of justification onto every use of real patient data.
In practice: Before processing sensitive patient data for bias testing or development, document whether synthetic or anonymised alternatives could fulfil the purpose, and justify why they cannot.
OmniGloss seed synthesis, 2026 (machine-drafted, pending expert validation)
For statistical offices, synthetic data is a disclosure-control instrument: generated microdata files that mimic survey or register data closely enough for researchers to develop code and for students to learn, while the confidential originals stay inside the office. Release practice treats synthesis as one more perturbation method inside the statistical-disclosure-control toolkit — synthetic files are risk-assessed like any other output, published with explicit utility warnings, and analytical results are expected to be re-run on the real data in a controlled environment before being cited in policy.
In practice: Publish synthetic microdata with documented generation method and utility limits, risk-assess it as a disclosure-control output, and require confirmatory runs on real data for policy use.
OmniGloss seed synthesis, 2026 (machine-drafted, pending expert validation)
Practitioner communities read the privacy evidence about data generation differently. Bank technology and vendor-management practice treats well-generated synthetic records as categorically non-personal: no record maps to a customer, so data-protection constraints fall away. Health-data researchers and statistical offices counter with empirical results — generative models memorize outliers, membership-inference attacks succeed against synthetic releases, and rare individuals can be reconstructed — so anonymity is a measured, per-release property rather than a consequence of the generation method itself.